Tai Hato
Social Insurance Saitama Chuo Hospital(JP)Saitama Medical University(JP)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cardiovascular Disease and Adiposity, Adipokines, Inflammation, and Metabolic Diseases, Cancer, Lipids, and Metabolism, Lipid metabolism and disorders
Most-Cited Works
- → CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice(2014)451 cited
- → Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma(2019)400 cited
- → The Role of Angiopoietin-Like Proteins in Angiogenesis and Metabolism(2008)356 cited
- → Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions(2014)242 cited
- → Rationally Combining Anti-VEGF Therapy with Checkpoint Inhibitors in Hepatocellular Carcinoma(2016)150 cited
- → Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma(2020)145 cited